Letermovir reduces chronic GVHD risk in calcineurin inhibitor-free GVHD prophylaxis after hematopoietic cell transplantation.
Francesca LorentinoElisabetta XueSara MastaglioFabio GiglioDaniela ClericiFrancesca FarinaSimona PiemonteseAlessandro BrunoLorenzo LazzariAnnalisa RuggeriElena GuggiariFrancesca LunghiAndrea A AssanelliSarah MarktelMagda MarcattiMatteo Giovanni Giovanni CarrabbaBernardi MassimoConsuelo CortiJacopo PeccatoriFabio CiceriRaffaella GrecoMaria Teresa Lupo StanghelliniPublished in: Blood advances (2022)